HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wright, A. Articles by Morrison, S. L. Search for Related Content PubMed PubMed Citation Articles by Wright, A. Articles by Morrison, S. L.

Effect of C2-Associated Carbohydrate Structure on Ig Effector Function: Studies with Chimeric Mouse-Human IgG1 Antibodies in Glycosylation Mutants of Chinese Hamster Ovary Cells¹

Department of Microbiology and Molecular Genetics and the Molecular Biology Institute, University of California, Los Angeles, Los, Angeles, CA 90095

The complex biantennary oligosaccharide at Asn²⁹⁷ of IgG is essential for some effector functions. To investigate the effect of carbohydrate structure on Ab function, we have now expressed mouse-human chimeric IgG1 Abs in Chinese hamster ovary (CHO) cells with defined defects in carbohydrate biosynthesis. We had previously shown that IgG1 Abs produced in the cell line Lec 1, which attaches a high-mannose intermediate carbohydrate, were severely deficient in complement activation, showed a slightly reduced affinity for FcRI, and had a reduced in vivo half-life. We have extended these studies by producing the same dansyl-specific IgG1 in cell lines deficient in attachment of sialic acid (Lec 2) and galactose (Lec 8). IgG1-Lec 1, IgG1-Lec 2, and IgG1-Lec 8 all showed varying reactivity with a mAb specific for an epitope in the amino terminal region of C_H2, suggesting that the conformations of these proteins were altered by the different carbohydrate structures. Functionally, IgG1-Lec 2 and IgG1-Lec 8 were comparable to wild type with respect to in vivo half-life, affinity for FcRI, and capacity for complement-mediated hemolysis. While IgG1-Lec 2 was essentially identical to wild type in its capacity to interact with individual components of the classical complement activation pathway, IgG1-Lec 8 demonstrated equivalent maximal binding at lower concentrations and was preferentially bound by mannose-binding protein. Although IgG1-Lec 1 was deficient in activation of the classical pathway, it had a superior capacity to activate the alternative pathway. These studies demonstrate that Abs bearing C_H2-linked carbohydrate of differing structures have different functional properties.

This article has been cited by other articles:

				M. Sack, A. Paetz, R. Kunert, M. Bomble, F. Hesse, G. Stiegler, R. Fischer, H. Katinger, E. Stoeger, and T. Rademacher Functional analysis of the broadly neutralizing human anti-HIV-1 antibody 2F5 produced in transgenic BY-2 suspension cultures FASEB J, June 1, 2007; 21(8): 1655 - 1664. [Abstract] [Full Text] [PDF]

				Y. Kanda, T. Yamada, K. Mori, A. Okazaki, M. Inoue, K. Kitajima-Miyama, R. Kuni-Kamochi, R. Nakano, K. Yano, S. Kakita, et al. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types Glycobiology, January 1, 2007; 17(1): 104 - 118. [Abstract] [Full Text] [PDF]

				Z. Yasukawa, C. Sato, K. Sano, H. Ogawa, and K. Kitajima Identification of disialic acid-containing glycoproteins in mouse serum: a novel modification of immunoglobulin light chains, vitronectin, and plasminogen Glycobiology, July 1, 2006; 16(7): 651 - 665. [Abstract] [Full Text] [PDF]

				P. R. Hinton, J. M. Xiong, M. G. Johlfs, M. T. Tang, S. Keller, and N. Tsurushita An Engineered Human IgG1 Antibody with Longer Serum Half-Life J. Immunol., January 1, 2006; 176(1): 346 - 356. [Abstract] [Full Text] [PDF]

				K. Ko, Z. Steplewski, M. Glogowska, and H. Koprowski Inhibition of tumor growth by plant-derived mAb PNAS, May 10, 2005; 102(19): 7026 - 7030. [Abstract] [Full Text] [PDF]

				M. Collin and V. A. Fischetti A Novel Secreted Endoglycosidase from Enterococcus faecalis with Activity on Human Immunoglobulin G and Ribonuclease B J. Biol. Chem., May 21, 2004; 279(21): 22558 - 22570. [Abstract] [Full Text] [PDF]

				K. Ko, Y. Tekoah, P. M. Rudd, D. J. Harvey, R. A. Dwek, S. Spitsin, C. A. Hanlon, C. Rupprecht, B. Dietzschold, M. Golovkin, et al. Function and glycosylation of plant-derived antiviral monoclonal antibody PNAS, June 24, 2003; 100(13): 8013 - 8018. [Abstract] [Full Text] [PDF]

				M. Collin, M. D. Svensson, A. G. Sjoholm, J. C. Jensenius, U. Sjobring, and A. Olsen EndoS and SpeB from Streptococcus pyogenes Inhibit Immunoglobulin-Mediated Opsonophagocytosis Infect. Immun., December 1, 2002; 70(12): 6646 - 6651. [Abstract] [Full Text] [PDF]

				R. L. Shields, J. Lai, R. Keck, L. Y. O'Connell, K. Hong, Y. G. Meng, S. H. A. Weikert, and L. G. Presta Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human Fcgamma RIII and Antibody-dependent Cellular Toxicity J. Biol. Chem., July 19, 2002; 277(30): 26733 - 26740. [Abstract] [Full Text] [PDF]

				Y. Mimura, P. Sondermann, R. Ghirlando, J. Lund, S. P. Young, M. Goodall, and R. Jefferis Role of Oligosaccharide Residues of IgG1-Fc in Fcgamma RIIb Binding J. Biol. Chem., November 30, 2001; 276(49): 45539 - 45547. [Abstract] [Full Text] [PDF]

				H. Bakker, M. Bardor, J. W. Molthoff, V. Gomord, I. Elbers, L. H. Stevens, W. Jordi, A. Lommen, L. Faye, P. Lerouge, et al. Galactose-extended glycans of antibodies produced by transgenic plants PNAS, February 27, 2001; 98(5): 2899 - 2904. [Abstract] [Full Text] [PDF]

				A. Wright, Y. Sato, T. Okada, K. H. Chang, T. Endo, and S. L. Morrison In vivo trafficking and catabolism of IgG1 antibodies with Fc associated carbohydrates of differing structure Glycobiology, December 1, 2000; 10(12): 1347 - 1355. [Abstract] [Full Text] [PDF]

				T.S. Raju, J. B. Briggs, S. M. Borge, and A. J. S. Jones Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics Glycobiology, May 1, 2000; 10(5): 477 - 486. [Abstract] [Full Text] [PDF]

				H. Kataoka, N. Kume, S. Miyamoto, M. Minami, T. Murase, T. Sawamura, T. Masaki, N. Hashimoto, and T. Kita Biosynthesis and Post-translational Processing of Lectin-like Oxidized Low Density Lipoprotein Receptor-1 (LOX-1). N-LINKED GLYCOSYLATION AFFECTS CELL-SURFACE EXPRESSION AND LIGAND BINDING J. Biol. Chem., February 25, 2000; 275(9): 6573 - 6579. [Abstract] [Full Text] [PDF]

				Y. Nagayama, H. Namba, N. Yokoyama, S. Yamashita, and M. Niwa Role of Asparagine-linked Oligosaccharides in Protein Folding, Membrane Targeting, and Thyrotropin and Autoantibody Binding of the Human Thyrotropin Receptor J. Biol. Chem., December 11, 1998; 273(50): 33423 - 33428. [Abstract] [Full Text] [PDF]